FindTrial
Sign In

Predictive value of renal artery resistance index combined with cystatin C for contrast-induced nephropathy

Predictive value of renal artery resistance index combined with cystatin C for contrast-induced nephropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020051
Enrollment
Unknown
Registered
2018-12-12
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-induced nephropathy

Interventions

CIN:no
Non-CIN:no

Sponsors

Zhongda Hospital of Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) aged = 18 years; (2) patients undergoing PCI

Exclusion criteria

Exclusion criteria: (1) end-stage renal disease requiring dialysis; (2) allergy to contrast agent; (3) intravascular administration of contrast medium within 2 weeks; (4) autoimmune diseases; (5) malignant tumor; (6) infectious diseases; (7) cardiac shock

Design outcomes

Primary

MeasureTime frame
SCr;Renal artery resistance index;Cystatin C;—

Countries

China

Contacts

Public ContactChengchun Tang

Zhongda Hospital of Southeast University

tangchengchun@hotmail.com+86 13914705570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026